Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 31, 2018
Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
Sonia Resik, Alina Tejeda, Ondrej Mach, et al.
Vaccine
|
June 9, 2016
Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013
Muhammad Atif Habib, Sajid Soofi, Ondrej Mach, et al.
The Lancet. Global Health
|
November 18, 2022
Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021
Azamdzhon Mirzoev, Grace R Macklin, Yiting Zhang, et al.
The Journal of Infectious Diseases
|
January 9, 2024
Mucosal Immunity to Poliovirus in Children 0-15 Years of Age: A Community-Based Study in Karachi, Pakistan in 2019
Ali Faisal Saleem, Zaubina Umar Kazi, Syeda Mahjabeen Zehra, et al.
The Pediatric Infectious Disease Journal
|
August 15, 2017
Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016
Imtiaz Hussain, Ondrej Mach, Atif Habib, et al.
The Journal of Infectious Diseases
|
June 27, 2019
Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus Vaccine
Sonia Resik, Ondrej Mach, Alina Tejeda, et al.
BMC Research Notes
|
October 12, 2018
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication
Nermeen M Galal, Safaa Meshaal, Rabab ElHawary, et al.
Vaccine: X
|
December 23, 2022
Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020
Marie Claire Endegue, Carolyn Sein, Rocio Lopez Cavestany, et al.
The Journal of Infectious Diseases
|
June 27, 2023
Two-Year Duration of Immunity of Inactivated Poliovirus Vaccine: A Follow-up Study in Pakistan in 2020
Ali Faisal Saleem, Sadia Parkar, Syeda Mahjabeen Zehra, et al.
The Journal of Infectious Diseases
|
October 16, 2014
Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series
Li Li, Olga Ivanova, Nadia Driss, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 31, 2018
Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
Sonia Resik, Alina Tejeda, Ondrej Mach, et al.
Vaccine
|
June 9, 2016
Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013
Muhammad Atif Habib, Sajid Soofi, Ondrej Mach, et al.
The Lancet. Global Health
|
November 18, 2022
Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021
Azamdzhon Mirzoev, Grace R Macklin, Yiting Zhang, et al.
The Journal of Infectious Diseases
|
January 9, 2024
Mucosal Immunity to Poliovirus in Children 0-15 Years of Age: A Community-Based Study in Karachi, Pakistan in 2019
Ali Faisal Saleem, Zaubina Umar Kazi, Syeda Mahjabeen Zehra, et al.
The Pediatric Infectious Disease Journal
|
August 15, 2017
Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016
Imtiaz Hussain, Ondrej Mach, Atif Habib, et al.
The Journal of Infectious Diseases
|
June 27, 2019
Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus Vaccine
Sonia Resik, Ondrej Mach, Alina Tejeda, et al.
BMC Research Notes
|
October 12, 2018
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication
Nermeen M Galal, Safaa Meshaal, Rabab ElHawary, et al.
Vaccine: X
|
December 23, 2022
Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020
Marie Claire Endegue, Carolyn Sein, Rocio Lopez Cavestany, et al.
The Journal of Infectious Diseases
|
June 27, 2023
Two-Year Duration of Immunity of Inactivated Poliovirus Vaccine: A Follow-up Study in Pakistan in 2020
Ali Faisal Saleem, Sadia Parkar, Syeda Mahjabeen Zehra, et al.
The Journal of Infectious Diseases
|
October 16, 2014
Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series
Li Li, Olga Ivanova, Nadia Driss, et al.
Page
of 7